Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Examorelin: Growth Hormone Secretagogue Comparison

Before selecting a GH secretagogue for a research protocol, understanding the functional and pharmacological differences between analogs clarifies which tool best fits the experimental question. Examorelin (Hexarelin) High GHS-R1a affinity; mild cortisol eleva

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Before selecting a GH secretagogue for a research protocol, understanding the functional and pharmacological differences between analogs clarifies which tool best fits the experimental question.
  • Examorelin (Hexarelin)
  • High GHS-R1a affinity; mild cortisol elevation at high doses
  • Very High (100 mcg ≈ 200 mcg GHRP-2)
  • Mild (dose-dependent)
  • Minimal
  • Moderate (2–4 weeks daily use)
  • Acute GH pulse studies; cardioprotective receptor signaling; short-term GH dynamics
  • GHRP-6
  • Moderate GHS-R1a affinity; strong orexigenic pathway activation
  • Moderate
  • High (significant appetite increase)
  • Appetite regulation studies; metabolic research
  • GHRP-2
  • Moderate GHS-R1a affinity; reduced appetite vs GHRP-6
  • Moderate-High
  • Mild
  • GH secretion studies where appetite confounds are reduced
  • Ipamorelin
  • High GHS-R1a selectivity; no secondary hormone activation
  • None
  • Chronic GH studies; protocols requiring no cortisol/prolactin confounds
  • MK-677 (Ibutamoren)
  • Non-peptide small molecule; long half-life (4–6 hrs)
  • Sustained elevation
  • Mild-Moderate
  • High
  • Chronic oral dosing studies; long-term GH exposure models
  • Examorelin's high receptor affinity makes it ideal for acute dose-response studies where maximizing GH output per administration is prioritized. Ipamorelin's lack of desensitization and secondary hormone effects make it the default choice for chronic (multi-week) protocols. MK-677's oral bioavailability and sustained GH elevation suit metabolic studies requiring stable daily GH exposure. GHRP-6 is largely deprecated in modern research due to its non-selective effects, but it remains useful in studies specifically investigating ghrelin's appetite-regulating functions.